Federal News

Displaying results 1-10 (of 70)
 |<  < 1 2 3 4 5 6 7  >  >| 

CSRO Discusses Part B and D with CMS

Members of CSRO’s executive board recently met with CMS to discuss Part B and D drug pricing. Doctors Michael Schweitz, Madelaine Feldman, Greg Schimizzi traveled to D.C. to present CSRO’s feedback on recent proposals and provide rheumatology’s perspective on the programs.

READ MORE

CSRO Responds to RFI Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs

CSRO has submitted their comments regarding the Request for Information (RFI) by the Department of Health and Human Services.

READ MORE

CSRO Presents on PBMs at the Board of Hispanic Caucus Chairs Conference

CSRO Vice President, Dr. Madelaine Feldman recently presented on Pharmacy Benefit Managers and utilization management tools at the Board of Hispanic Caucus Chairs meeting in Las Vegas, Nevada.

READ MORE

FDA Biosimilars Educational Material

To date, the U.S. Food and Drug Administration (FDA) has approved seven biosimilars, and some are already on the market. As the biosimilars market continues to grow, there are still a lot of questions from both patients and physicians about these important new treatment options.

READ MORE

CSRO Opposes Efforts to Establish a National Benchmark Plan Standard for Prescription Drugs

The CSRO has submitted comments to CMS expressing concerns with their intent to establish a national benchmark plan standard for prescription drugs in future years.

READ MORE

CSRO Responds to Federal Innovation Center RFI

The CSRO has responded to a request for information (RFI) from the Innovation Center as the federal agency plans for a new direction. The comments submitted focus on specific issues that uniquely impact practicing rheumatologists and the patients they serve.

READ MORE

CSRO Presents at the Patient and Health Advocacy Bio Summit

Dr. Madelaine Feldman traveled to Washington D.C. recently to attend the Patient and Health Advocacy Bio Summit.

READ MORE

CSRO Submits Comments to CMS on Proposed Revisions for 2018

As patient and physician advocates, the CSRO actively monitors regulatory changes that affect physician’s ability to effectively treat their patients and operate their practices. As such, the CSRO took note of and discussed revisions proposed by the Center for Medicare and Medicaid Services for 2018.

READ MORE

Escalating Cost of Prescription Drugs Facilitated by Lack of Transparency

The expansive list of actors involved in delivering prescription drugs to patients substantially inhibits patients from making fully informed treatment and purchasing decisions.

READ MORE

Patient Rights Report Fingers Insurer Practices as Impediment to Patient Access

The Doctor-Patient Rights Project recently released a new study concerning barriers to healthcare access for patients. Titled: Not What the Doctor Ordered, the report focuses on how intrusions by insurers in the patient –physician relationship have forced many patients to forgo the treatments they need.

READ MORE

Displaying results 1-10 (of 70)
 |<  < 1 2 3 4 5 6 7  >  >|